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Abstract: In this work, we prepared silver nanowires (AgNWs) via the polyol method in the presence
or absence of single wall carbon nanotubes (CNTs) and tested their physicochemical, antibacterial
and cytotoxic properties. Results showed that the introduction of CNTs lead to the formation of
AgNWs at lower temperature, but the final product characteristics of AgNWs and AgNWs-CNT
were not significantly different. AgNWs exhibited antibacterial properties against all the studied
bacterial species via the formation of oxygen reactive species (ROS) and membrane damage.
Furthermore, AgNWs exhibited a dose-dependent and time-dependent toxicity at concentrations ≥
10 µg/mL. Fibroblasts appeared to be more resistant than human colorectal adenocarcinoma (Caco-2)
and osteoblasts to the toxicity of AgNWs. The cytotoxicity of AgNWs was found to be related to
the formation of ROS, but not to membrane damage. Overall, these results suggest that AgNWs are
potential antibacterial agents against E. coli, S. aureus, MRSA and S. saprophyticus, but their dosage
needs to be adjusted according to the route of administration.
Keywords: silver nanowires; nanomaterials; biocompatibility
1. Introduction
Silver has been known for centuries for its antimicrobial properties against a wide range of
microorganisms. In the 1980s the first findings on the unique properties of nanoparticles (NPs) were
published, researchers started to investigate novel applications for silver nanomaterials in electronic,
optical and biomedical fields. In order to satisfy specific needs, several morphologies have been
developed, including silver nanospheres, nanocubes, nanorods, nanotriangles and nanowires.
Silver nanowires (AgNWs) are one-dimensional silver structures and are currently being intensively
studied for thermal and electronic applications due to their excellent conductive properties [1–3].
Despite the fact that the antibacterial and cytotoxic properties of other silver nanoparticles have been
widely explored [4–8] and medical devices loaded with silver nanopoarticles have been developed,
research on AgNW antibacterial properties, mechanisms of action and possible biomedical applications
is still scarce [9]. So far we know that AgNWs are potential antibacterial agents against E. coli
and S. aureus, but we know little about how they exert their action. Visnapuu et al., for instance,
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stated that the toxicity of AgNWs against E. coli was due to dissolved Ag+ ions rather than to
a direct effect of the silver nanostructures [10]. Cui and Liu, instead, highlighted that E. coli is more
sensitive than S. aureus to the action of AgNWs, determining their toxicity was a consequence of both
AgNW-induced bacterial disruption and the induction of ROS generation [11].
In the development of AgNWs containing commercial products, we must be considerate of the fact
that nanowires can be released into the environment during manufacturing, use or disposal; thus, there
is a compelling need to understand the short- and long-term toxicity of these materials in humans [12].
Other high-aspect ratio materials, such as asbestos or carbon nanotubes, have indeed been shown to
be actively absorbed into eukaryotic cells, causing different types of damage [13]. As the respiratory
route is one of the major access routes linked to occupational exposure to AgNWs, the majority of
studies have so far focused on the possible damages through this route. Schinwald et al. found that
AgNWs longer than ≥14 µm or ≥ 5 µm were able to induce pleural inflammation, in vivo and in vitro,
respectively [14]. Further studies have also highlighted that AgNWs can enter and accumulate in
epithelial cells, interstitial sites, airway smooth muscle cells, the vascular endothelium, the pleural
membrane and macrophages. Stoehr et al. compared the cytotoxicity of AgNWs (length: 1.5–25 µm;
diameter 100–160 nm) and Ag nanospheres (30 nm) against human alveolar epithelial cells (A549),
finding that whereas no effects were observed for the spherical particles, significantly reduced cell
viability and increased LDH release were induced by AgNWs [15]. A recent review on the safety of
nanosilver has highlighted that, at the nanoscale, silver nanowires are safer than silver nanoparticles
due to their hindered cellular uptake [16].
In light of this diverse evidence, and in particular, the results considering different routes of
administration, this study aimed to investigate the in vitro antibacterial properties of AgNWs obtained
via two synthetic methods (soft template and heterogeneous method) tested against E. coli, S. aureus,
MRSA and S. saprophyticus. Moreover, the internalization, cytotoxicity and possible mechanisms of
action of AgNWs against human osteoblasts (hFOB 1.19), human skin fibroblasts (Hs27) and human
colorectal adenocarcinoma (Caco-2) were studied in order to assess future potential applications such
as inclusion in bone implants or in wound dressings for skin and mucosa.
2. Results
2.1. AgNW Physicochemical Characterisation
2.1.1. UV-vis and TEM Characterization
AgNWs were synthesized via the polyol method using PVP as a soft template, and AgNWs-CNT
were synthesized with the same method in the presence of carbon nanotubes (CNTs) in order to evaluate
whether the addition of CNTs influenced the morphological, physical and biological properties of
the AgNWs. AgNWs-CNT-mix (physical mixture of AgNWs and CNTs) was used as a control to
investigate whether any potential difference between AgNWs in AgNWs-CNT was due to the mere
presence of CNTs or if they had an effect when introduced in the synthetic procedure. The UV-Vis
spectra of AgNWs and AgNWs-CNT at low temperatures showed a peak at 410 nm, indicative
of the formation of nucleation sites with the initial presence of silver nanoparticles and nanorods
(Figure 1A–B). A shift towards lower wavenumbers and the formation of a double peak (350 and 380 nm)
were observed as the temperature increased, indicating the formation of longer structures such
as nanowires [17]. The shift was observed at lower temperatures when the synthesis of AgNWs
was performed in the presence of CNTs; this could be due to the excellent heat conductivity of
CNTs that can affect the reaction kinetics. Nanoparticles were also observed by TEM (Figure 1C–F);
images confirmed the successful formation of AgNWs under both synthetic conditions. However,
in both cases, other types of nanoparticles, such as nanospheres and nanorods, were visualized.
Moreover, the amount of CNTs found in AgNWs-CNT appeared significantly inferior to that in
the AgNWs-CNT-mix. Interestingly, in both AgNWs-CNT and AgNWs-CNT-mix samples, the smaller
particles tended to align along the surface of CNTs (Figure 1G–H). A size analysis was performed
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based on SEM images (Figures S1 and S2); average lengths were 5.23 µm (± 1.5), 5.21 µm (± 2.7)
and 5.04 µm (± 1.7), for AgNWs, AgNWs-CNT and AgNWs-CNT-mix, respectively. Average diameters
were 73.70 nm (± 25.79), 67.04 nm (± 25.23) and 68.54 nm (± 17.47) for AgNWs, AgNWs-CNT
and AgNWs-CNT-mix, respectively. One-way ANOVA showed no significant difference in lengths
and diameters across all three materials (p > 0.05).
Figure 1. Physicochemical characterization of synthesized products. UV-spectra of (A) AgNWs and (B)
of AgNWs-CNT at different temperatures during the synthesis reaction. TEM images of (C) AgNWs
(scale bar 500 nm), (D) AgNWs-CNT (scale bar 500 nm), (E) AgNWs-CNT-mix (scale bar 500 nm)
and (F) CNTs (scale bar 500 nm). (G) Silver release from AgNWs, AgNWs-CNT and AgNWs-CNT-mix
measured by ICP-OES and expressed as wt/wt%. (H) Silver contents measured by ICP-OES in AgNWs,
AgNWs-CNT and AgNWs-CNT-mix (n = 3). One-way ANOVA returned p < 0.05; Post-hoc Tukey’s
multicomparison test, *** p = 0.001 when comparing all the formulations to AgNWs, and $$$ p = 0.003
when comparing AgNWs-CNT to AgNWs-CNT-mix.
2.1.2. Total Silver Content and Ag+ Release
The total Ag content in each of the products and the cumulative Ag+ released over time were
determined. The total silver content found in AgNWs (97.33 ± 1.14 wt/wt%) was higher than that
in AgNWs-CNT (89.11 ± 1.25 wt/wt%), but not significantly different (one-way ANOVA, p > 0.05,
Figure 1H); this explains the observation of only a few CNTs in the TEM images (Figure 1C–E).
The amount of Ag in AgNWs-CNT-mix was significantly inferior to the other two batches (35.27 ± 5.33
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wt/wt%) (p< 0.001), as expected. The release of Ag+ from AgNWs, AgNWs-CNT and AgNWs-CNT-mix
(Figure 1G) started immediately in the aqueous solution and its concentration increased over time.
After 30 min, the concentration of Ag+ in suspension was ca. 0.31 ± 0.04 ppm from AgNWs, 0.22 ± 0.17
ppm from AgNWs-CNT and 0.09 ± 0.02 ppm from AgNWs-CNT-mix. After 2 days, the percentage of
Ag+ released was of ca. 0.32 wt/wt% from AgNWs, 0.23 wt/wt% from AgNWs-CNT and 0.71 wt/wt%
from AgNWs-CNT-mix (one-way ANOVA p > 0.05), corresponding to 1.15 ± 0.39, 0.95 ± 0.53 and 0.92
± 0.81 ppm, respectively.
2.1.3. XRD, Photoluminescence and ζ-Potential Analyses
The X-ray diffraction (XRD) pattern of AgNWs (Figure 2A) corresponds to the structure of metallic
silver; in particular, the sharp peaks at 2θ values of 38.1◦, 44.3◦, 64.4◦ and 77.3◦ refer to the reticular
planes (111), (200), (220) and (311), and are typical of AgNWs [18]. Furthermore, the (111)/(200) peak
ratio was 3.7, indicating the formation of well-elongated AgNWs [19]. Minimal trace impurity of AgCl
can be seen at a 2θ value of 32.1◦ and 46.2◦ [20].
Figure 2. XRD pattern and fluorescence spectra. (A) XRD pattern of AgNWs (pink) and AgNWs-CNT
(blue); red bars: Ag, PDF No. 04-0783; blue bars: AgCl, PDF n. 31-1238. (B) XRD pattern of AgNWs
(violet), AgNWs-CNT-mix (black) and CNTs (green). (C) The emission fluorescence peaks of AgNWs
(red), AgNWs-CNT-mix (black), CNTs (grey) and water (blue). (D) Fluorescence microscope image
of AgNWs-CNT in water; the white arrow indicates AgNWs, and the yellow arrow indicates CNTs
(scale bar 200 µm).
Superimposed patterns of AgNWs and AgNWs-CNT confirmed that the two synthetic processes
led to similar products. The (111)/(200) intensity ratio of AgNWs-CNT was 3.2. The XRD profile of
CNTs (Figure 2B) showed broad peaks at 2θ angles of ≈26◦, ≈43◦ and ≈57◦, corresponding to the (002)
plane of graphite and to the (111) and (200) reflections of carbon, respectively [21]; these peaks also
featured in AgNWs-CNTs-mix. The (111)/(200) intensity ratio of AgNWs-CNT-mix was found to be
3.2, similar to AgNWs-CNT. The fluorescence emission of AgNWs, AgNWs-CNT and CNTs aqueous
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solutions was also investigated. Excitation at wavelengths between 390 and 400 nm led to fluorescence
emission between 450 and 600 nm with lambda maxima at 465 nm, corresponding to the blue-green
emitting region. The luminescence emission from silver clusters and silver nanoparticles of different
dimensions has previously been described [22,23], but not entirely understood. This phenomenon
could be related to the number and position of surface plasmon resonance (SPR), which in turn depends
on the size and shape of silver clusters.
Surface zeta potential (ζ) was found to be negative for all the preparations (AgNWs −12.43 ±
1.23 mV; AgNWs-CNT −18.24 ± 5.92 mV; AgNWs-CNT-mix −19.8 ± 7.66 mV); the values indicated
that electrostatically stable suspensions cannot be obtained in water without the use of a suspending
agent [10].
2.2. Antibacterial Properties
2.2.1. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)
The potential bacteriostatic and bactericidal activities of the synthesized materials were tested
against four different bacterial species: E. coli, S. aureus, MRSA and S. saprophyticus. In order to
compare the activity of AgNWs, AgNWs-CNT, AgNWs-CNT-mix and ionic silver (as AgNO3), the MIC
and MBC values obtained were normalized to the amount of Ag present in each material.
All studied materials inhibited or stopped cell growth within the tested concentration range,
except for single-wall carbon nanotubes-COOH (tested as control), which did not show any antibacterial
response (Table 1). All preparations were less efficient than AgNO3 in both inhibiting cell growth and in
promoting cell death apart from S. saprophyticus that was highly sensitive to all treatments. Normalized
MIC and MBC values of AgNWs, AgNWs-CNT and AgNWs-CNT-mix were not statistically different
from each other (p > 0.05) against all the different bacterial species; only S. aureus AgNWs-CNT-mix
showed a lower efficacy (p < 0.001). Overall, S. saprophyticus was found to be the most sensitive strain
against silver nanowires, whereas MRSA was the most resistant. The MIC values found in this study
for E. coli and S. aureus were higher than those reported by Cui and Liu for AgNWs (28 and 35 µg/mL
to E. coli and S. aureus, respectively) [11] and Hong et al. (> 100 µg/mL against E. coli) [24]; this can be
explained considering the differences in initial bacterial density, nanowire dimensions and methods
adopted for the MIC and MBC determination [25].
2.2.2. Bacterial Growth Kinetics
In order to study how the bacterial growth kinetics were influenced by different concentrations of
studied materials, growth was followed by measuring OD.600nm in LB medium (Figure 3, Figures S3
and S4). Seemingly for MIC and MBC studies, CNTs did not appear to influence bacterial growth
kinetics (Figure S3). AgNWs affected both the lag phase (100 µg/mL, p < 0.05) and the time to
reach the stationary phase (50 µg/mL, p < 0.05) of E. coli (Figure 3A and Figure S5). MRSA showed
a significantly longer lag phase than the control only in the presence of AgNWs 100 µg/mL (p < 0.01)
but no effect on the time to reach the stationary phase (Figure 3E and Figure S5). S. aureus (Figure 3C)
was more sensitive than MRSA and E. coli to the action of AgNWs: all the tested concentrations,
except for 12.5 µg/mL, produced longer lag phases (25 µg/mL p < 0.001; 50 and 100 µg/mL p < 0.0001).
The time to reach the stationary phase was statistically longer for concentrations equal to or higher
than 50 µg/mL (p < 0.05). The lag phase duration of S. saprophyticus (Figure 3G and Figure S5) was
increased for the two lowest concentrations (12.5 µg/mL p < 0.01 and 25 µg/mL p < 0.05), whereas no
growth was found for the higher concentrations of nanowires, and the time to reach the stationary
phase was significantly longer even for the lowest tested concentration. E. coli was more sensitive to
AgNWs-CNT (Figure 3A and Figure S5) than AgNWs: its lag phase (12.5 µg/mL, p < 0.05, whereas
25, 50 and 100 µg/mL had a p < 0.0001) and the time to reach stationary phase were also significantly
longer for the lowest concentration. Seemingly, S. aureus (Figure 3D) was more sensitive to the action
of AgNWs-CNT than AgNWs with decreased growth at all concentrations tested and no growth
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at the highest concentration. No difference in the time to reach the stationary phase was found for
concentrations 12.5 and 25 µg/mL in comparison to the control (Figure S5). MRSA (Figure 3F) growth
was affected by AgNWs-CNT at all concentrations. No effect on the time to reach the stationary phase
was observed. S. saprophyticus lag phase (Figure 3H and Figure S5) was affected for the two lowest
concentrations (p < 0.05), and no growth was observed for the higher concentrations. The time to reach
the stationary phase of S. saprophyticus was statistically longer for the 25 µg/mL concentration than
for the control. For all the studied nanowires and bacterial strains, whenever the stationary phase
was reached, no statistical difference in OD values was found among treated and untreated bacteria
(Figure S5). The ability of AgNWs to retard cell growth was further demonstrated by fluorescence
imaging (Figure S6).
Table 1. MIC and MBC values (mg/mL) for AgNWs, AgNWs-CNT, AgNWs-CNT-mix, AgNO3
and CNTs. Data are reported as the mean ± SD (n ≥ 3). One-way ANOVA results are reported in
the table. The post hoc Tukey multiple comparisons test results are shown with *when compared
to Ag+ and with $when compared to AgNW-CNT-mix. *,$ p < 0.05; **,$$ p < 0.01, ***,$$$ p < 0.001
and ****,$$$$ p < 0.0001.
Microorganism Material MIC (mg/mL) MBC (mg/mL) MBC/MIC
E. coli
Anova
MIC p < 0.0001
MBC p < 0.0001
AgNWs 0.42 ± 0.26 * 1.16 ± 0.27 $$ 2.8
AgNWs-CNT 0.53 ± 0.54 *$$$ 1.38 ± 0.55 *** 2.6
AgNWs-CNT-mix 0.49 ± 0.07 *** 0.99 ± 0.16 *** 2.0
AgNO3 0.01 ± 0.00 0.17 ± 0.05 17
CNTs > 3.00 > 3.00 -
S. aureus
Anova
MIC p < 0.0001
MBC p < 0.05
AgNWs 0.36 ± 0.24 $$$ 1.55 ± 0.63 4.3
AgNWs-CNT 0.28 ± 0.24 $$$ 1.05 ± 0.80 2.9
AgNWs-CNT-mix 0.44 ± 0.12 0.77 ± 0.16** 1.8
AgNO3 0.01 ± 0.00 $$$ 0.1 ± 0.00 10
CNTs > 3.00 > 3.00 -
MRSA
Anova
MIC p < 0.01
MBC p < 0.0001
AgNWs 1.07 ± 0.40 * 2.53 ± 0.53 **** 2.4
AgNWs-CNT 0.85 ± 0.85 * 2.00 ± 0.44 ****$$ 2.4
AgNWs-CNT-mix 0.67 ± 0.14 * > 3.00 **** -
AgNO3 0.01 ± 0.00 0.07 ± 0.05 7
CNTs > 3.00 > 3.00 -
S. saprophyticus
Anova
MIC p < 0.05
n.s.
AgNWs 0.25 ± 0.21 0.66 ± 0.42 2.7
AgNWs-CNT 0.08 ± 0.00 0.72 ± 0.60 9
AgNWs-CNT-mix 0.08 ± 0.06 0.46 ± 0.36 5.8
AgNO3 0.01 ± 0.00 0.01 ± 0.00 1
CNTs > 3.00 > 3.00 -
2.2.3. Leakage of Proteins From Bacteria
Cui and Liu reported that AgNWs could cause the leakage of cytoplasmic contents, such as DNA
and proteins, from E. coli [11]. This phenomenon may be due to several alterations in bacterial
cells, such as the inhibition of the activity of membranous enzymes or DNA damage. In the present
study, a bicinchoninic acid (BCA) assay was used to determine whether AgNWs obtained by the two
methods induced the release of proteins in the extracellular liquid. All the bacterial species tested
showed an increased release of proteins in comparison to the control (Figure 4A–H). Moreover,
this effect was dose-dependent, but no difference was found between 1 or 24 h after treatment,
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except for S. saprophyticus. A higher amount of proteins leaked out of E. coli compared to S. aureus
and MRSA, suggesting that gram-negative bacteria are more sensitive than gram-positive bacteria
to the action of AgNWs on the integrity of the membrane. This is justified by the barrier function
of the thicker peptidoglycan found in gram-positive bacteria and is in agreement with previous
studies [26]. No statistical difference was found between AgNWs and AgNWs-CNT, when comparing
the same concentrations. SEM images confirmed the cell membrane damage caused by AgNWs,
particularly in E. coli (Figure S8).
Figure 3. Growth curves of bacteria with different concentrations of AgNWs (A,C,E,G)
and AgNWs-CNT (B,D,F,H). Results are reported as the mean ± SD (n = 3).
Int. J. Mol. Sci. 2020, 21, 2303 8 of 22
Figure 4. Absorbance relative to protein release after 1 and 24 h of treatment for E. coli (A,B), S. aureus
(C,D), MRSA (E,F) and S. saprophyticus (G,H) treated with 12.5 or 100 µg/mL of AgNWs or AgNWs-CNT.
Data are presented as the mean ± SD (n = 4). The one-way ANOVA performed on all the samples
showed significantly different releases for both AgNWs and AgNWs-CNT (p < 0.05). Results of
the post-hoc Tukey multicomparison test are shown in the graphs (* indicates p < 0.05, ** indicates
p < 0.01, *** indicates p < 0.001 and **** indicates p < 0.0001).
2.2.4. ROS Generation From Bacteria
Previous studies suggested that oxidative stress plays a crucial role in the mechanism of toxicity
of silver nanoparticles versus bacterial cells. In this work, extracellular ROS production was quantified
24 h after treatment with nanowires (Figure 5A–H). ROS were produced when S. aureus and E. coli were
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treated with all types of metallic nanoparticles in a dose-dependent manner, as previously reported for
other types of AgNPs [27].
MRSA did not show significantly increased ROS generation, similar to S. saprophyticus treated with
AgNWs; but when S. saprophyticus was treated with AgNWs-CNT, there was a statistically significant
increase in ROS at concentrations equal to or higher to 25 µg/mL. On the contrary, AgNWs were found
to produce statistically more ROS than AgNWs-CNT in E. coli and S. aureus (unpaired two tailed t-test
for: a) E. coli: 100 p < 0.05; 12.5 µg/mL, p < 0.01; b) S. aureus: 100 µg/mL, p < 0.05). See Figure S7 for
data obtained for all concentrations tested.
Figure 5. ROS production (% of the control) from bacterial cells, 24 h from treatment. E. coli (A,B),
S. aureus (C,D), MRSA (E,F) and S. saprophyticus (G,H) treated with 12.5 and 100 µg/mL of AgNWs
or AgNWs-CNT. Data are presented as the mean ± SD (n = 3). The one-way ANOVA performed on
all the samples showed significantly different ROS production for both AgNWs and AgNWs-CNT
(p < 0.05) for some of the bacterial strains. Results of the post-hoc Tukey multicomparison test are
shown in the graphs (* indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates
p < 0.0001).
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2.3. Cytotoxicity Studies
The toxicity of the two types of AgNWs was tested against three cell lines: osteoblasts (hFOB 1.19),
human foreskin fibroblasts (Hs27) and Caco-2 cells (Figure 6A–F). These cell lines were chosen to mimic
three possible routes of exposure such as the application of treatments to bone, skin and the digestive
system, respectively [28]. No signs of acute toxicity were observed, as after 2 h of treatment, no cell
line showed a significant decrease in cell viability (p > 0.05). After 24 h of exposure, fibroblasts were
the more robust cells as their viability did not show a significant decrease with increasing doses of
AgNWs and AgNWs-CNTs. Caco-2 cells were the most sensitive, with a significant decrease in viability
at doses of 25 µg/mL of AgNWs (p < 0.001) and 10 µg/mL of AgNWs-CNTs (p < 0.001).
Figure 6. Cytotoxicity observed in different types of cell lines after 2 and 24 h of treatment. Osteoblasts
(A,B), fibroblasts (C,D), Caco-2 (E,F). Data are presented as the mean± SD (n> 3). The one-way ANOVA
performed on all samples showed significantly different viability for AgNWs and AgNWs-CNT (*
indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates p < 0.0001).
2.3.1. Oxidative Stress in Eukaryotic Cells
Several studies have shown that AgNPs induce the production of ROS in mammalian cells [29,30].
Results of the present study (Figure 7A–F) confirmed that ROS induced by AgNWs and AgNWs-CNT
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are an important factor in promoting toxicity, but once again, the effect is specific to the cell line treated.
Fibroblasts presented the lowest level of ROS produced when treated with AgNWs-CNTs and with
no significant effect when treated with AgNWs. Osteoblasts were the most sensitive to the AgNW
treatment, with a higher level of ROS detected. Caco-2 cells presented a wider range of variability
that caused non-significant differences when compared to the control. CNTs were tested as a control
and induced no significant ROS production in any of the cell lines (Figure S9). Few other studies are
available for AgNWs; Sweeney et al. reported that AgNWs (72 nm × 1.5 µm) could induce a significant
increase in ROS production in human type-I epithelial-like cells (TT1), both after 4 (≥25 µg/mL) and 24 h
treatment (≥ 10 µg/mL) [31].
Figure 7. Time course of ROS production in different cell lines: osteoblasts (A,B), fibroblasts (C,D)
and Caco-2 (E,F) treated with AgNWs or AgNWs-CNT for 15 min. One-way ANOVA returned p < 0.05.
Data are reported as the mean ± SD (n = 3). Results of the post-hoc Tukey multicomparison test are
shown in the graph: *was used to compare 100 with 0 µg/mL (* indicates p < 0.05 and ** indicates
p < 0.01); $ was used to compare 10 with 0 µg/mL ($ indicates p < 0.05 and $$ indicates p < 0.01).
2.3.2. Membrane Damage Evaluation
Membrane integrity was assessed by measuring extracellular lactate dehydrogenase (LDH,
Figure 8). No significant toxicity was observed after 24 h for any of the concentrations tested in
comparison to the spontaneous LDH release (0 µg/mL) (p > 0.05).
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2.3.3. Silver Uptake
Previous studies have reported that AgNWs are taken up and accumulate in different types of
lung cells, such as alveolar type-I and type-II epithelial cells [31]. In our work, we wanted to find out
if AgNWs are also taken up in other cell lines and at which concentration. Cells were treated with
Ag+, AgNWs or AgNWs-CNT for 24 h. Concentrations up to 10 µg/mL were tested as they caused no
relevant differences in toxicity to osteoblasts after 24 h of exposure (Figure 9).
Figure 8. Percentage LDH release from osteoblasts, fibroblasts and Caco-2 after 24 h of exposure
to different concentrations of AgNWs or AgNWs-CNTs. The one-way ANOVA calculated among
the different concentrations of each test did not show statistical differences (p > 0.05). Data are reported
as the mean ± SD (n = 3).
AgNWs were up taken by all cell lines more efficiently than Ag+ (Tukey’s multicomparison
test showed p < 0.0001) and in a concentration-dependent manner. A similar behavior was found
with mammalian kidney cells (Pk15) for silver nanoparticles of different sizes (ca. 13.8–61.2 µm) by
Milic et al. [32]. We hypothesized that as there is no specific transporter for Ag+, it has to compete
for transporters with other ionic species, and the amount of Ag that entered in the cells was inferior
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in comparison to AgNWs that can enter by endocytosis. Results of ICP-OES were confirmed by
fluorescence microscopy for osteoblasts (Figure 10), where AgNWs accumulated either close to
the membrane (Figure 10F) or within the cytoplasm (Figure 10F–I).
Figure 9. Uptake of silver by (A) osteoblasts, (B) fibroblasts and (C) Caco-2 treated with AgNWs,
AgNWs-CNT and AgNO3. Data are expressed as the mean ± SD (n = 3). One way Anova indicated
at least p< 0.05 for all samples tested apart from AgNO3. Results of the post-hoc Tukey multicomparison
test are shown in the graph (symbol *compared to 0.1 and # compared to 10 µg/mL).
3. Discussion
The present study aimed to investigate both the antibacterial efficacy and the eukaryotic
cytocompatibility of silver nanowires in vitro, as well as to test the effect of silver nanowire composite
materials in combination with carbon nanotubes (based on previous reports of enhanced activity of
silver nanowires combined with graphene) [11]. In this work, AgNWs-CNT-mix (a physical mixture
of AgNWs and CNTs) was used as a control to further investigate the role of CNTs in the synthesis
and properties of the composite material. Silver nanowires were successfully synthesized both in
the presence and in absence of carbon nanotubes using the soft template method, as confirmed by
UV-VIS, XRD and EM imaging. The average size (ca. 70 nm in diameter and 5 µm in length) and silver
content in both materials were similar. In the soft template synthesis of AgNWs, a coordination complex
is formed between silver ions and PVP through donation of lone-pair electrons of oxygen and nitrogen
atoms of PVP to sp orbitals of the metallic silver reduced by glycerol [33]. We hypothesized that
–COOH groups of CNTs can interact with Ag+, forming the first nucleation centers for the growth
of silver nanowires. TEM images supported the theory that nucleation centers form on the surface
of carbon nanotubes and lead to the formation of nanowires along the axis of CNTs. Furthermore,
size and silver content data suggest that whereas CNTs might have played a role in the nucleation
and reduction of heat required in the synthesis (as seen on UV-Vis spectra), they are not chemically
bound to AgNWs, and as a consequence, they are removed during the purification process. The release
of Ag+ from the nanowires was also studied; the silver ion concentration was higher than 0.1 ppb
(minimum effective concentration [34]) already after 30 min, suggesting that these nanomaterials are
potential platforms for Ag+ controlled release for antibacterial purposes. In fact, even though AgNO3
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is a more potent antibacterial agent than AgNWs, free silver ions may not act in the long term, as they
can be easily washed away by physiological fluids, whereas silver nanowires can act as reservoirs
and allow for a sustained release of therapeutic doses [35].
Figure 10. Phalloidin Dylight 550- and DAPI-stained osteoblast cells at 24 h of incubation with AgNWs
(10 and 100 µg/mL). (A,D) and (G): merged images of Phalloidin (staining F-actin) and DAPI (staining
nuclei) of osteoblasts. (B,E) and (H): AgNWs excited at 495 nm and emitting at 519 nm. (C,F) and (I):
merged images of Phalloidin/DAPI/AgNWs. Scale bar 270 µm.
As MIC and MBC values appeared to be similar among AgNWs, AgNWs-CNT
and AgNWs-CNT-mix, we could assume that the three preparations had similar antibacterial properties
(with no effect due to the presence of CNTs). Moreover, as reported by Cavassin et al., in order to
reduce the selection of resistant microorganisms, antimicrobials should present an MBC/MIC ratio
≤4; this was found to be the case with AgNWs against all bacteria tested, apart from S. aureus for
which the value was 4.3 [36]. In our study, we showed that AgNWs had a bactericidal effect against all
the isolates, except for MRSA. The antibacterial activity of AgNWs and AgNWs-CNTs was tested in
suspension, and the growth kinetics of all the bacterial strains tested were affected by the treatment
but in different ways. Similar results were observed by Cui et Liu, who described the influence of
increasing concentrations of AgNWs on E. coli growth [11]. However, whereas they showed growth
inhibition at concentrations higher than 25 µg/mL, in the present study, none of the concentrations
used could inhibit cell growth in the same time frame. Variations in the results can be due to microbial
strains, but also to physicochemical characteristics of the AgNW suspension, for instance, the presence
of PVP [37]. In our study, MRSA was found to be the least sensitive, whereas S. saprophyticus was
the most susceptible. These results indicate that it is not possible to explain the species sensitivity to
silver nanoparticles in terms of bacterial classification (gram-positive and gram-negative), but that there
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are more specific differences among species [37]. MRSA has been previously described as susceptible
to AgNPs, with evident membrane damage shown by TEM images; the damage was attributed to
charge interaction between positively charged nanoparticles and negatively charged peptidoglycan,
and only the smaller particles (dia. < 20 nm) were observed to enter the cells [38]. In the case of AgNWs,
the negative charge and longer length might hinder the interaction with MRSA and reduce efficacy.
In this regard, we previously observed that the combination of AgNWs with the positively charged
polymer chitosan had a synergistic effect on AgNW efficacy against MRSA [39]. The mechanism of
bacterial toxicity was further investigated with a focus on membrane damage and ROS production.
The bacterial toxicity of AgNWs was mainly mediated through oxidative stress, in the case of
E. coli and S. aureus, whereas the ROS levels in MRSA were not significantly changed at the tested
concentrations, supporting the theory that MRSA could present more efficient antioxidant mechanisms
than E. coli and S. aureus. In this regard, Grinholc et al. found that MRSA was more resistant than
S. aureus to photodynamic inactivation, a therapeutic means based on the generation of ROS. The exact
reason for this difference was not identified, but evidence led to excluding that it was related to
the multidrug resistance mechanisms developed by MRSA [40]. When tested on human cell lines,
silver nanowires did not show acute toxicity. A significant decrease in cell viability was observed only
after prolonged treatment, as previously described [41]. This toxicity could be reduced if the silver
nanowires are formulated as part of a device, such as a wound healing dressing or a bone regeneration
scaffold. This was shown by Verma et al., who found that silver nanowire toxicity was greatly reduced
when not tested as free wires but as part of a thin film [41]. No evidence of membrane damage was
observed for any of the cell lines tested. Gliga et al. previously observed that LDH release from human
lung cells (BEAS-2) depended on the dimensions of the AgNPs. Testing particles of 10, 40 and 75 nm,
they found no significant LDH release for the NPs ≥ 40 nm diameter [42]. Thus, we hypothesize that
AgNWs may cause less membrane damage than other AgNPs due to their size. In conclusion, we did
not observe any advantage of the use of carbon nanotubes to form AgNW composites. We confirmed
the potential use of AgNWs as slow release reservoirs of silver ions. The use of silver nanowires for
biomedical applications could be advantageous in applications where a slow and sustained release is
required, and embedding of AgNWs in delivery platforms such as wound healing bandages can be
used as a strategy to reduce potential cytotoxicity.
4. Materials and Methods
4.1. Materials
2′,7′-Dichlorofluorescin diacetate (≥97%), acetone, agar, chitosan from shrimp shells with low
viscosity (degree of deacetylation ~85%, calculated by H1-NMR), dimethyl sulfoxide anhydrous,
(≥99.9%), glutaraldehyde solution, hexamethyldisilazane (≥99%), sodium chloride, octaldehyde (99%),
poly(vinylpyrrolidone) powder (55 kDa), phosphate-buffered saline tablets, a silver standard for AAS,
sodium cacodylate trihydrate, trypsin-EDTA 0.25% solution, tryptone enzymatic digest from casein,
Triton™ X-100 and yeast extract for microbiology were purchased from Sigma–Aldrich (Irvine, UK).
Ethanol, glycerol (99%), hydrochloric acid (37%), isopropanol, L-(+)-lactic acid (90 %) and sodium
borohydride were purchased from Acros Organics (Geel, Belgium). 3-(4, 5-dimetheylthiazol-2)-2,
5 diphenyl tetrazolium bromide (MTT), 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI),
dimethylformamide, DMEM (high glucose, with GlutaMAXTM and pyruvate), fetal bovine serum
(FBS), Hank’s Balanced Salt Solution (HBSS), HPLC-grade water, methanol, nitric acid (70%),
penicillin/streptomycin solution, phalloidin dylight 550, Pierce ™ BCA Protein Assay and silver
nitrate were purchased from Fisher (Loughborough, UK). Single-wall carbon nanotubes-COOH
OD 1–4 nm (SW-CNTs) were purchased from Cheaptubes.com (Grafton, VT). Corning DMEM/F12
(with L-glutamine and 15 mM HEPES) was purchased from Scientific Laboratory Supplies (UK).
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4.2. Synthesis and Characterization of AgNWs
4.2.1. Synthesis of AgNWs and Composites
AgNWs were synthesized via the polyol method, as previously described [43]. AgNWs-CNT
were synthetized in the presence of CNTs with a slightly modified method. After complete dissolution
of PVP in glycerol, 5.8 mg of carbon nanotubes was added and sonicated for 2 h to favor dispersion.
After sonication, the synthetic procedure was the same as that used for AgNWs. The reaction progress
was monitored by UV-Vis in the wavelength range of 300–600 nm (Thermo Scientific Nicolet Evolution
100 UV-Visible Spectrophotometer, Loughborough, UK). As a control, a physical mixture of CNTs
and AgNWs (AgNWs-CNT mix) was prepared. Briefly, N-octyl-O-sulphate chitosan (NOSC, 10 mg,
synthetized as previously described [44]) was dissolved in 10 mL of purified water before the addition
of 12.5 mg of CNTs. The sample was sonicated for 4 h. Then, 40 mL of deoxygenated water and 2 g of
PVP were added to the mixture. The mixture was then heated and maintained at 80 ◦C for 30 min.
AgNWs in deoxygenated water (10 mL, 1.5 mg/mL) were then added to the reaction mixture; this was
stirred at 800 rpm for 6 h in the dark. The sample was then centrifuged at 2880 g for twenty minutes
and the supernatant removed. This step was repeated twice. The solid pellet obtained was then
washed and stored as previously described [43].
4.2.2. Characterization of AgNWs and Composites
Freeze-dried samples were suspended in deionized water at a concentration of 0.1 mg/mL;
suspensions were dropped onto TEM grids (Agar scientific square mesh TEM support grids—copper)
and allowed to dry at room temperature and pressure; no further treatment was applied. Dry grids
were stored in sealed Petri dishes in a desiccator until analysis with an FEI CM120 BioTwin transmission
electron microscope. The crystal structure of the samples was determined with a Bruker D2-Phaser
diffractometer. Instrumental parameters were as follows: CuKα radiation, 30kV, 10 mA, LynxEye
PSD detector with an angular opening of 5◦, 2θ range 10◦–80◦, step size 0.020◦, time per step 1 s,
spinner 7.5 rpm. The alignment of the instrument was calibrated using an international standard
(NIST 1976b). A low-background silicon crystal specimen holder (Bruker) was used. The analyses
were performed at 26 ± 2◦C. The XRD patterns were evaluated using Bruker EVA 14.2 (DIFFRACplus
Package) software coupled with the database PDF-2 (ICDD). The total silver content and silver release
were determined after digesting the freeze-dried samples in an equal volume of MilliQ water and 70%
nitric acid. The volume of digested samples was brought up to 20 mL with MilliQ water. Finally,
the solutions containing CNTs were filtered five times by a glass microfiber filter (GF/D). The silver
content was determined by an inductively coupled plasma optical emission (ICP-OES) spectrometer
(Spectroblue OEP-TI, Ametek, Germany) equipped with an ASX-520 autosampler. External calibration
was performed by analysis of a blank and five solutions of dissolved AgNO3 standard in 2% HNO3
ranging from 0 to 100 µg L−1. The charged Ag ions were measured at two wavelengths (328.068
and 328.289 nm), and the results were averaged. The ICP-OES was equipped with Spectro Smart
Analyzer software (vs. 6.01.0943). The set parameters for the analysis were as follows: 1450 W for
plasma power, 30 rpm for pump speed, 13 L/min for coolant flow and 0.75 L/min for nebulizer flow.
Ag+ release from nanoparticles was determined as previously reported [43]. In order to determine
whether either AgNWs or CNTs possessed any autofluorescence, freeze-dried NPs were suspended
in deionized water and sonicated to provide a homogeneous suspension. Samples were excited
at different wavelengths (390, 488, 550, 570, 633 and 670 nm), and the respective emission spectra
were recorded. Images of the suspensions were then acquired by fluorescence microscopy (Zeiss Axio
Imager Z1). Surface zeta potentials were measured using a Malvern Zetasizer (Nano ZS, Malvern, UK).
Nanoparticles were suspended by sonication in deionized water. On average, twelve measurements
per samples were carried out. The selected refractive index for silver nanoparticles was 1.333.
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4.3. Antibacterial Activity
4.3.1. Bacterial Culture Preparation
The antibacterial activity of AgNWs was examined by a suspension assay against gram-negative
E.coli (ATCC 25922) and gram-positive S. aureus (ATCC 25923), methicillin-resistant S. aureus (ATCC
12403) and S. saprophyticus (ATCC 15305). The bacteria were transferred from −80 ◦C (30% glycerol) into
5 mL of fresh sterile LB by a sterile toothpick and incubated (at 37 ◦C and 200 rpm) until the bacterial
suspension was cloudy (1 day for E.coli and S. aureus, 2 days for MRSA and 3 days for S. saprophyticus)
(MaxQ™ 8000, Thermo Scientific). Then, 50 µL of the bacterial suspension was transferred into 5 mL
of fresh sterile LB, and the bacteria were further incubated at 37 ◦C until the suspension was newly
cloudy (1 day for E. coli, S. aureus and MRSA and 2 days for S. saprophyticus).
4.3.2. Preparation of Stock Solutions of Antibacterial/Cytotoxic Agents
Stock suspensions (10 mg/mL) of NPs were prepared in deionized water and were then diluted
in the appropriate medium. AgNO3 was dissolved in water in order to obtain an Ag+ concentration
of 10 mg/mL. All suspensions and the silver nitrate solutions were sonicated for 2 h in order to obtained
homogenous preparations.
4.3.3. Determination of the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal
Concentration (MBC)
Bacterial suspensions were prepared as described above. Samples were tested at a range of
concentrations (10, 100, 200, 500, 750, 1000, 1500, 2000 and 3000 µg/mL) against bacterial suspensions
(107 CFU/mL) to a final volume of 150 µL in 96 well plates. Medium with only bacteria served
as a negative control. Then, the plates were incubated at 37 ◦C for 24 h with gentle shaking (60 rpm).
The absorbance was read at 600 nm using the appropriate blank suspensions/solutions. MIC was
determined through spectrophotometry as the lowest concentration visibly inhibiting the bacterial
growth. MBC was determined by transferring 25 µL samples from each well onto a LB agar plate.
After overnight incubation (12 h), the total number of colonies appearing on the culture plate was
assessed. The MBC was determined as the concentration at which there was no microbial growth.
All experiments were performed in duplicate.
4.3.4. Bacterial Growth Kinetics
The effect of the prepared samples on bacterial growth kinetics was assessed as previously
described [43].
4.3.5. Protein Leakage From Bacteria
Bacteria were grown as described above and then centrifuged (13,000 g for 5 min), and the pellets
were suspended in sterile PBS (pH 7.4) to a final concentration of 0.6 CFU/mL in the presence of
two concentrations of samples to be tested: 12.5 and 100 µg/mL. Bacteria were incubated at 37 ◦C
and 200 rpm. After 1 and 24 h incubation, 1 mL of sample was taken from each test tube and centrifuged
(13,000 g for 5 min). The supernatant was then stored at −20 ◦C until further analysis. The bicinchoninic
assay (Pierce ™ BCA Protein Assay) was carried out according to the manufacturer’s instructions.
Briefly, 25 µL samples were mixed with 200 µL of working solution. Sample absorbance was read
at 562 nm after two hours of incubation at 37 ◦C. The experiment was carried out in duplicate.
4.3.6. Extracellular ROS Production
To determine levels of ROS generated, a fluorescent probe was used; 2, 7- dichlorofluorescein
diacetate (DCFH-DA) is converted to highly fluorescent 2, 7- dichlorofluorescein (DCF) in the presence
of reactive oxygen species (H2O2, HO• and ROO•). Initially, the DCFH-DA probe was suspended in
Int. J. Mol. Sci. 2020, 21, 2303 18 of 22
DMSO at a 10 mM concentration before being diluted with LB medium to create a 100 µM working
solution. After 24 h of incubation of bacteria with the test samples, 1 mL samples were removed
and centrifuged at 1300 rpm for 1 min. The supernatant (40 µL) was removed and incubated with
60 µL of the fluorescent probe for 30 min in the dark at 37 ◦C. Using an excitation wavelength of
485 nm and an emission wavelength of 520 nm, the fluorescence of the samples was read on a bench
top fluorimeter (Agilent Cary Eclipse).
4.4. Cytotoxicity Studies
4.4.1. Cell Culture
Human fetal osteoblasts (hFOB 1.19), human foreskin fibroblasts (Hs27) and human colorectal
adenocarcinoma cells (Caco-2) were purchased from ATCC®. hFOB were maintained at 37 ◦C in 5%
CO2 in a flask in Dulbecco’s Modified Eagle’s Ham/F12 medium (with L-glutamine and 12 mM HEPES)
containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S). Hs27 were maintained
under the same physical conditions but using DMEM (high glucose, with GlutaMAXTM and pyruvate),
10% FBS and 1% P/S. Caco-2 cells were maintained at 37 ◦C in 5% CO2 in MEM containing 10% FBS,
1% P/S, 2 mM L-glutamine and 1% non-essential amino acids (NEAA). Cell lines were used between
passage 4 and 12.
4.4.2. Cell Viability
Cell viability was evaluated by the MTT [3-(4, 5-dimetheylthiazol-2)-2, 5 diphenyl tetrazolium
bromide] colorimetric technique. Briefly, 5000 cells/ well were plated in a 96-well plate with 100 µL
of complete medium and incubated overnight to permit cell attachment. Stock suspensions of test
samples in complete medium were sonicated for 4 h at 40 Hz. Aliquots of initial AgNW suspensions
were added to the cell medium to final concentrations of 0.1, 1, 10, 25, 50 and 100 µg/mL. After 24 h of
incubation, 100 µL of treatments were added to each well containing cells and incubated for 2 and 24 h.
At these time points, the treatments were removed and cells were treated with 100 µL of complete
medium containing MTT (0.5 mg/mL). The cells were incubated for 4 h in a 5% CO2 incubator for
reduction of MTT by metabolically active cells. The reagent was removed, and the purple formazan
crystal inside the cells was solubilized with 100 µL of DMSO. The formazan content was quantified by
spectrophotometry at a wavelength of 570 nm (SpectraMax® i3x, Molecular Devices). DMSO served
as a blank. The experiments were carried out at least in triplicate.
4.4.3. Cell Membrane Integrity
To evaluate cell membrane integrity, the lactate dehydrogenase (LDH) leakage assay was performed.
Cells were plated at 10,000 cells/well. Then, cells were treated with nanoparticles in complete medium
containing 2% FBS (as the serum may interfere with the assay). Spontaneous activity and maximum LDH
activity were used as controls. The assay was carried out according to the manufacturer’s instructions
(Pierce ™ LDH cytotoxicity assay). The absorbance was read at 490 and 680 nm. The absorbance
read at 680 nm (background) was subtracted from the 490 nm absorbance before the calculation of
LDH release.
4.4.4. Intracellular ROS Production
Cells were plated in a sterile black 96-well plate at 25,000 cells/well in 100 µL of medium. Cells were
incubated for 24 h; then, the medium was removed, and the cells were washed once with sterile HBSS
containing Ca and Mg. Cells were further incubated with DCFH-DA 28 µM in HBSS for 45 min.
After washing with HBSS, the cells were treated with the complete medium (2% FBS), containing
the test samples, for desired periods of time. Fluorescence was measured as described in Section 4.3.6.
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4.4.5. Silver Uptake by Cells
Cells were plated at 30,000 cells/well (1 mL medium) in a 24-well plate and incubated for
24 h, as described above. Cells were exposed to nanoparticles at different concentrations (1 mL).
After 24 h of exposure, the medium was removed, and the cells were gently washed twice with
cold PBS to remove loosely attached Ag ions and/or NPs from the cell membrane. To each well,
HPLC grade water (600 µL) was added, and then 70% HNO3 (600 µL). The nanoparticles were then
digested for 20 min, and the solutions were brought to 21 mL with HPLC grade water. Controls were
made with just cells. The silver content was determined by an inductively coupled plasma optical
emission (ICP-OES) spectrometer (Spectroblue OEP-TI, Ametek, Germany) equipped with an ASX-520
autosampler. External calibration was performed by analysis of a blank and five solutions of dissolved
Ag in 2% HNO3 ranging from 0 to 100 µg L−1. The charged Ag ions were measured at two wavelengths
(328.068 and 328.289 nm), and the results were averaged. The ICP-OES was equipped with SPECTRO
SMART ANALYZER software (vs. 6.01.0943). The set parameters for the analysis were 1450 W for
plasma power, 30 rpm for pump speed, 13.00 L/min for coolant flow and 0.75 L/min for nebulizer flow.
4.4.6. Fluorescence Imaging of AgNW Uptake
Cells were seeded on coverslips at a cell density of 10000 cells/well in 24-well plates (300 µL
of medium). After overnight incubation at 37 ◦C and 5% CO2, cells were treated with AgNWs.
At scheduled time points, cells on coverslips were fixed directly with paraformaldehyde (4%) in PBS
(pH 7.4) for 15 min, washed with PBS, permeabilized for 10 min in 0.1% Triton X-100/PBS, washed
twice with PBS, blocked with 2% bovine serum albumin (BSA) in PBS for 1 h, washed twice with
PBS, stained with Phalloidin Dylight 550 in PBS (2 units/mL, stock solution 300 units/mL in methanol)
for 1 h (300 µL, at room temperature), washed twice with PBS, stained with DAPI 2 µg/mL in PBS for
10 min and finally rinsed again with PBS. Coverslips were mounted on glass slides using PermaFluor
Aqueous Mounting Medium. Samples were kept protected from light until imaging. Photos were
taken with a fluorescence microscope (Zeiss Axio Imager Z1) equipped with a Hamamatsu HR camera
and a color AxioCam MRc camera. Images were processed by Volocity 6.3 software.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/7/2303/
s1.
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AgNWs Silver nanowires
AgNWs-CNT Silver nanowires prepared in the presence of carbon nanotubes
AgNWs-CNT-mix Silver nanowire and carbon nanotube physical mixture
CNTs Carbon nanotubes
ROS Reactive oxygen species
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